| Literature DB >> 6410918 |
W R Gold, J T Queenan, J Woody, R A Sacher.
Abstract
Four pregnancies managed with erythrocyte membrane oral therapy because of severe Rh disease are presented. Reduction in anti-(D) production was the goal of the study. A patient was classified as having severe Rh immunization if there was a history of fetal loss due to erythroblastosis fetalis prior to 26 weeks.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6410918 DOI： 10.1016/0002-9378(83)90978-x
Source DB: PubMed Journal: Am J Obstet Gynecol ISSN： 0002-9378 Impact factor: 8.661